New Wearable Migraine Treatment for Those Age 12 and Older
Jennifer McVige, director of the Concussion Center at the DENT Neurologic Institute in New York, and board-certified in pediatric neurology, adult and p...
819 articles
Jennifer McVige, director of the Concussion Center at the DENT Neurologic Institute in New York, and board-certified in pediatric neurology, adult and p...
Milton, a 68-year-old from Beulah, AL shares his experience of becoming 98 percent cancer free after his participation in a clinical trial for a recentl...
Maya Said shares her personal story and how she came to co-found the Outcomes4Me free app to help simplify the process and improve outcomes for breast c...
Vicki Goodman, VP, Therapeutic Area Head, Late Stage Oncology at Merck discusses the recent Phase 3 KEYNOTE-204 positive EU CHMP opinion for expanded ap...
Ed Tracy, an award-winning broadcast veteran, writer, and editor discusses his new book "Gorilla In The Room And Other Stories" (Feb 2021) which started...
Colon cancer is the second deadliest cancer impacting both men and women, but it’s considered preventable if caught in earlier stages when it is most...
Astellas Oncology has announced the three finalists for the 2020 C3 Prize (Changing Cancer Care). One of the finalists, Lisa McKenzie is here to share...
Dave Marver, CEO of ONWARD, discusses the work they are doing with both non-invasive and implantable neuromodulation technologies to improve the quality...
Paul Brennan, President and CEO of NervGen Pharma Corp, developer of treatments related to nerve damage and neurodegenerative diseases, discusses the st...
Tania Gonzalez-Rivera, MD, BENLYSTA Global Medical Affairs Lead at GlaxoSmithKline (GSK) discusses the recent FDA approval of BENLYSTA (Belimumab) the f...